These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 30460680)
1. Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C Br J Haematol; 2019 Jun; 185(5):951-954. PubMed ID: 30460680 [No Abstract] [Full Text] [Related]
2. Clinical Significance of Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907 [No Abstract] [Full Text] [Related]
3. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma. Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646 [TBL] [Abstract][Full Text] [Related]
4. Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups? Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of 'double-hit' and 'double-expression' lymphomas. Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842 [TBL] [Abstract][Full Text] [Related]
6. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas. Willenbacher E; Willenbacher W; Weger R; Dominik W; Manzl C; Brunner A Ann Hematol; 2020 Sep; 99(9):2125-2132. PubMed ID: 32613279 [TBL] [Abstract][Full Text] [Related]
7. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type. Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208 [TBL] [Abstract][Full Text] [Related]
8. High-grade B-cell lymphoma with Scott DW; King RL; Staiger AM; Ben-Neriah S; Jiang A; Horn H; Mottok A; Farinha P; Slack GW; Ennishi D; Schmitz N; Pfreundschuh M; Nowakowski GS; Kahl BS; Connors JM; Gascoyne RD; Ott G; Macon WR; Rosenwald A Blood; 2018 May; 131(18):2060-2064. PubMed ID: 29475959 [TBL] [Abstract][Full Text] [Related]
9. Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients. Krull JE; Wenzl K; Hartert KT; Manske MK; Sarangi V; Maurer MJ; Larson MC; Nowakowski GS; Ansell SM; McPhail E; Habermann TM; Link BK; King RL; Cerhan JR; Novak AJ Blood Cancer J; 2020 Nov; 10(11):117. PubMed ID: 33168821 [TBL] [Abstract][Full Text] [Related]
10. The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas. Naseem M; Asif M; Khadim MT; Ud-Din H; Jamal S; Shoaib I Asian Pac J Cancer Prev; 2020 Apr; 21(4):1103-1107. PubMed ID: 32334477 [TBL] [Abstract][Full Text] [Related]
12. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data]. Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736 [TBL] [Abstract][Full Text] [Related]
13. Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements. Alsharif R; Dunleavy K Hematol Oncol Clin North Am; 2019 Aug; 33(4):587-596. PubMed ID: 31229156 [TBL] [Abstract][Full Text] [Related]
14. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741 [TBL] [Abstract][Full Text] [Related]
15. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry. Lešková K; Szépe P; Balhárek T; Barthová M; Janáková Ľ; Farkašová A; Plank L Neoplasma; 2022 Jul; 69(4):957-964. PubMed ID: 35652622 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234 [TBL] [Abstract][Full Text] [Related]
17. Mutational landscape of high-grade B-cell lymphoma with Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985 [TBL] [Abstract][Full Text] [Related]
18. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma. Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304 [TBL] [Abstract][Full Text] [Related]
20. [The incidence of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in diffuse large B-cell lymphoma]. Li M; Zhang QL; Zhao W; Huang X; Gong LP; Shi QF; Liu CL; Gao ZF Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):124-128. PubMed ID: 33858042 [No Abstract] [Full Text] [Related] [Next] [New Search]